Navigation Links
Georgetown professor applauds decision of researchers to temporarily halt research on H5N1
Date:1/23/2012

WASHINGTON, DC A Georgetown University Medical Center professor says the voluntary action taken by two research teams to temporarily halt work involving the highly pathogenic avian influenza H5N1 is "laudable."

In the researchers' statement, published today by Science and Nature, the authors stated that they "recognize that we and the rest of the scientific community need to clearly explain the benefits of this important research and the measures taken to minimize its possible risks." The statement comes in the wake of a debate following the U.S. government's request that Science and Nature withhold scientific information related to the genetically modified H5N1 virus because of biosecurity concerns.

"This is a laudable decision to make sure that all voices are heard on such an important issue," says John D. Kraemer, JD, MPH, assistant professor of health systems administration at Georgetown University School of Nursing & Health Studies. Trained in both public health and the law, Kraemer conducts scholarship on public health law and ethics, with a particular focus on the ethical and legal limits of governmental action to address health concerns.

"The moratorium will provide an opportunity for institutions to assess the best way of overseeing dual use research that which has both significant potential for public health benefits and a chance for harm," he adds.

In 2011, two research teams one from the United States and one from the Netherlands announced that they had genetically modified the H5N1 avian influenza virus in such a way that it could possibly spread rapidly among humans. They estimated that half of those who would contract the engineered virus would die (the research was conducted in an animal model believed to represent human behavior of the virus). Their work, funded by the National Institutes of Health (NIH), was submitted independently to the journals Nature and Science for publication. The National Science Advisory Board for Biosecurity (NSABB), which advises the Department of Health and Human Services (HHS), recommended that Science and Nature redact key information prior to publication out of concern that published details about the papers' methodology and results could become a blueprint for bioterrorism.

On January 19, Kraemer and his colleague, Lawrence O. Gostin, the Linda D. and Timothy J. O'Neill Professor of Global Health Law at Georgetown University Law Center, published an invited opinion on the topic for Science's "Policy Forum." ("The Limits of Government Regulation of Science" 19 Jan 2012).

In it, Kraemer and Gostin said the U.S. government's request that the journals Science and Nature withhold that scientific information does not violate the First Amendment. They advised, however, that a fair, transparent process undertaken by research organizations is preferable to governmental constraints on disseminating scientific information.

"The NSABB process seems to have worked well in this instance," says Kraemer. "It raised legitimate security concerns while avoiding censorship of the scientific press. But there remains a need to strengthen precautions around this type of research before scientific censorship occurs."


'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. Georgetown researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers
2. FDA awards Georgetown University a Center of Excellence in Regulatory Science & Innovation
3. Georgetown research identifies key reasons racial disparities exist in emergent stroke treatment
4. FDA and Georgetown University Medical Center announce partnership
5. Georgetown Research Center Helps Reporters Decipher Health Reform Law & Impact on State Residents
6. Georgetown University Center for Children and Families Hails Health Reform As Big Win for Children and Families
7. NSF grant will aid Wayne State professors mathematical modeling of fatty liver predictors
8. Louisiana Tech professor co-edits book on computational analysis of human eye
9. New book by University of Louisville professor enables reader to develop personalized anti-depression plan
10. Professor Doug Hilton wins Research Australia Award
11. Cell death research wins professor Andreas Strasser 2011 Victoria Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... ... Advanced Inc., a leading provider of travel therapy and travel nursing across ... Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as Vice ... leadership experience to Advanced Inc. He began his career in finance at Ernst & ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... interview of two ostomy patients, standing as living proof that attitude and determination ... digestive diseases and issues that spike around the holidays. This campaign will offer ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized ... fulfilling lives. “We are prolonging life 6 years in the last 3 decades,” ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology: